Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.
Brief Summary: This a Phase III trial designed to determine if IV casopitant plus dexamethasone and ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and ondansetrone alone following the administration of moderately emetogenic oxaliplatin-based chemotherapy.


Options:
A: Arm Label: Netupitant and Palonosetron+dexamethasone-cycle 1; Type: EXPERIMENTAL; Interventions: Drug: Netupitant and Palonosetron, Drug: Dexamethasone | Arm Label: Palonosetron+dexamethasone-cycle 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palonosetron, Drug: Dexamethasone | Arm Label: Netupitant and Palonosetron+dexamethasone-multicycle extension; Type: EXPERIMENTAL; Interventions: Drug: Netupitant and Palonosetron, Drug: Dexamethasone | Arm Label: Palonosetron+dexamethasone-multicycle extension; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palonosetron, Drug: Dexamethasone | Intervention Type: DRUG; Name: Netupitant and Palonosetron; Assigned to Arm(s): Netupitant and Palonosetron+dexamethasone-cycle 1, Netupitant and Palonosetron+dexamethasone-multicycle extension | Intervention Type: DRUG; Name: Palonosetron; Assigned to Arm(s): Palonosetron+dexamethasone-cycle 1, Palonosetron+dexamethasone-multicycle extension | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Netupitant and Palonosetron+dexamethasone-cycle 1, Netupitant and Palonosetron+dexamethasone-multicycle extension, Palonosetron+dexamethasone-cycle 1, Palonosetron+dexamethasone-multicycle extension
B: Intervention Type: DRUG; Name: Palonosetron; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Granisetron; Assigned to Arm(s): N/A
C: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dexamethasone, Drug: Placebo, Drug: Ondansetron | Arm Label: Single Dose IV; Type: EXPERIMENTAL; Interventions: Drug: Casopitant, Drug: Dexamethasone, Drug: Ondansetron | Intervention Type: DRUG; Name: Casopitant; Assigned to Arm(s): Single Dose IV | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Control, Single Dose IV | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Control, Single Dose IV
D: Arm Label: Netupitant and Palonosetron plus dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Netupitant and Palonosetron, Drug: Dexamethasone | Arm Label: Aprepitant and Palonosetron plus dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aprepitant, Drug: Palonosetron, Drug: Dexamethasone | Intervention Type: DRUG; Name: Netupitant and Palonosetron; Assigned to Arm(s): Netupitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Palonosetron; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone, Netupitant and Palonosetron plus dexamethasone

Answer: C